Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.

274 total trials for this combination

Showing top 10 of 274 trials

Trials

NCT ID	Title	Status	Phase
NCT01991795	A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus	COMPLETED	PHASE3
NCT01179048	Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results	COMPLETED	PHASE3
NCT07064473	EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	RECRUITING	—
NCT02065791	Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy	COMPLETED	PHASE3
NCT07064473	EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	RECRUITING	—
NCT00474630	A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes	COMPLETED	PHASE3
NCT07064473	EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	RECRUITING	—
NCT00968708	Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome	COMPLETED	PHASE3
NCT07064473	EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	RECRUITING	—
NCT07064473	EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	RECRUITING	—

Related Pages

All Diabetes mellitus, type 2 trials All trials in Dallas, United States